Thanks for the call update CN, has Mr James ever mentioned anything about protecting the intellectual property that may be developed through the CBD supplement formulation process? I'm aware of the Charlottes Web trademark, but am referring to patents on the actual product..
Honestly, I think the only thing keeping the PPS propped up where it currently stands is the expected upcoming news about their CBD line of supplements. When that news hits, I see the PPS moving much higher, at least for a short while.
Just taking a quick peak at their most recent quarterly FINS, it's difficult to see how the company might attract new investors wiling to take the risk, or even keep those that have been in it for any length of time. Their gross profit for the 1st quarter was only 117K, with the preferred divy being about double that amount. After admin expenses, royalties, divies, and everything in between, you're left with a net loss of around 4.7M for the quarter which stinks compared to their revenues, and anticipated revenues. Page eight of their quarterly filing explains briefly the company's going concern and liquidity issues.
While they might be able to decrease their overall admin expenses a bit after the CBD line is out for a while, you're still left with increasing royalties from MSE. Unless the numbers start to improve dramatically in the next few quarters, then they may require a national ad campaign to try and move the products and turn a profit. They'd need a LOT of $$$ to make it happen, so it's unlikely that such a campaign would exist.